{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:10:23Z","timestamp":1740820223888,"version":"3.38.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09236"],"award-info":[{"award-number":["18K09236"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s43032-025-01795-w","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T17:53:16Z","timestamp":1738777996000},"page":"702-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Azurocidin is Associated with Dienogest-resistance in Ovarian Endometriotic Cysts"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8203-7565","authenticated-orcid":false,"given":"Momoe","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tanigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"1795_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jama.2014.17119","volume":"313","author":"J Brown","year":"2015","unstructured":"Brown J, Farquhar C. An overview of treatments for endometriosis. JAMA. 2015;313:296\u20137.","journal-title":"JAMA"},{"unstructured":"United Nations Population Division. Contraceptive use by method 2019: data booklet. https:\/\/digitallibrary.un.org\/record\/3849735?v=pdf. Accessed 7 Feb 2020.","key":"1795_CR2"},{"key":"1795_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00011-015-0909-7","volume":"65","author":"G Grandi","year":"2016","unstructured":"Grandi G, Mueller M, Bersinger N, Cangnacci A, Volpe A, McKinnon B. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res. 2016;65:183\u201392.","journal-title":"Inflamm Res"},{"key":"1795_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.fertnstert.2016.10.022","volume":"106","author":"P Vercellini","year":"2016","unstructured":"Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Feritil Steril. 2016;106:1552\u201371.","journal-title":"Feritil Steril"},{"key":"1795_CR5","first-page":"27","volume":"6","author":"T Harada","year":"2010","unstructured":"Harada T, Taniguchi F. Dienogest: a new therapeutic agent for the treatment of endometriosis. Women\u2019s Health. 2010;6:27\u201335.","journal-title":"Women\u2019s Health"},{"key":"1795_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","volume":"73","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008;73:222\u201331.","journal-title":"Steroids"},{"key":"1795_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3109\/09513590.2016.1147547","volume":"32","author":"K Adachi","year":"2016","unstructured":"Adachi K, Takahashi K, Nakamura K, Otake A, Sasamoto N, Miyoshi Y, Shoji M, Yoshimatsu Y, Fujirani M, Wakimoto A, Tokuhira A, Kobayashi E, Yoshimura A, Sawada K, Kimura T. Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas. Gynecol Endocrinol. 2016;32:646\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"1795_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1447-0756.2009.01076.x","volume":"35","author":"M Momoeda","year":"2009","unstructured":"Momoeda M, Harada T, Terakawa N, Aso T, Fukunaga M, Hagino H, Taketani Y. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res. 2009;35:1069\u201379.","journal-title":"J Obstet Gynaecol Res"},{"key":"1795_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/BF03345616","volume":"31","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa S, Shimizu Y, Nagaoka T, Tokado H, Imada K, Mizuguchi K. Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys. J Endocrinol Invest. 2008;31:636\u201341.","journal-title":"J Endocrinol Invest"},{"key":"1795_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.fertnstert.2011.09.040","volume":"96","author":"S Mita","year":"2011","unstructured":"Mita S, Shimizu Y, Notsu T, Imada K, Kyo S. Dienogest inhibits toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells. Fertil Steril. 2011;96:1485\u20139.","journal-title":"Fertil Steril"},{"key":"1795_CR11","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.fertnstert.2004.11.042","volume":"83","author":"S Horie","year":"2005","unstructured":"Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells. Fertil Steril. 2005;83:1530\u20135.","journal-title":"Fertil Steril"},{"key":"1795_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13577-020-00465-0","volume":"34","author":"Y Kobayashi","year":"2021","unstructured":"Kobayashi Y, Toshiyuki F, Mita S, Watanabe M, Suzuki A. Identification of biomarkers for drug-resistant endometriosis using clinical proteomics. Hum Cell. 2021;34:394\u20139.","journal-title":"Hum Cell"},{"key":"1795_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.18388\/abp.2003_3665","volume":"50","author":"W Watorek","year":"2003","unstructured":"Watorek W. Azurocidin\u2013 inactive serine proteinase homolog acting as multifunctional inflammatory mediator. Acta Biochim Pol. 2003;50:743\u201352.","journal-title":"Acta Biochim Pol"},{"key":"1795_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1189\/jlb.0808495","volume":"85","author":"O Soehnlein","year":"2009","unstructured":"Soehnlein O, Lindbom L. Neutrophil-derived azurocidin alarms the immune system. J Leukoc Biol. 2009;85:344\u201351.","journal-title":"J Leukoc Biol"},{"key":"1795_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jre.12703","volume":"55","author":"D Nelmpantis","year":"2020","unstructured":"Nelmpantis D, Gatou A, Fragkioudakis I, Margariti A, Lemonia S, Sakellari D. Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis. J Periodontal Res. 2020;55:209\u20132014.","journal-title":"J Periodontal Res"},{"doi-asserted-by":"crossref","unstructured":"Ipek E, Yolcu M, Yildirim E, Altinkaynak K, Ozbek Sebin S, Kalkan K, Gulcu O, Ermis E, Ozturk M. A novel marker of inflammation: azurocidin in patients with ST segment elevation myocardial infarction. Int J Mol Sci. 2018;19:3797.","key":"1795_CR16","DOI":"10.3390\/ijms19123797"},{"key":"1795_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ghir.2011.04.003","volume":"21","author":"K Brandt","year":"2011","unstructured":"Brandt K, Lunedell K, Brismar K. Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and\u2013\u20094. Growth Horm IGF Res. 2011;21:167\u201373.","journal-title":"Growth Horm IGF Res"},{"key":"1795_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.fertnstert.2005.08.046","volume":"85","author":"PA Klemmt","year":"2006","unstructured":"Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril. 2006;85:564\u201372.","journal-title":"Fertil Steril"},{"key":"1795_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2559.2011.03817.x","volume":"58","author":"S Sugita","year":"2011","unstructured":"Sugita S, Morishita Y, Kano J, Furuya S, Shibata-Ishii A, Noguchi M. IGFBP-1 is expressed specifically in ovarian clear cell adenocarcinoma. Histopathology. 2011;58:729\u201338.","journal-title":"Histopathology"},{"key":"1795_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"JL Kenneth","year":"2001","unstructured":"Kenneth JL, Thomas DS. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CTmethod. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"doi-asserted-by":"crossref","unstructured":"Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2015; 111: A3.B.1-A3.B.3.","key":"1795_CR21","DOI":"10.1002\/0471142735.ima03bs111"},{"key":"1795_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.fertnstert.2017.01.001","volume":"107","author":"SS Singh","year":"2017","unstructured":"Singh SS, Suen MW. Surgery for endometriosis: beyond medical therapies. Fertil Steril. 2017;107:549\u201354.","journal-title":"Fertil Steril"},{"key":"1795_CR23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/jog.13725","volume":"44","author":"A Koshiba","year":"2018","unstructured":"Koshiba A, Mori T, Okimura H, Akiyama K, Kataoka H, Takaoka O, Ito F, Matsushima H, Kusuki I, Kitawaki J. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. J Obstet Gynaecol Res. 2018;44:1970\u20136.","journal-title":"J Obstet Gynaecol Res"},{"key":"1795_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13048-014-0108-0","volume":"7","author":"Y Chen","year":"2014","unstructured":"Chen Y, Pei H, Chang Y, Chen M, Wang H, Xie H, Yao S. The impact endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-mulllerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108.","journal-title":"J Ovarian Res"},{"key":"1795_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00404-015-3681-6","volume":"292","author":"M Andres","year":"2015","unstructured":"Andres M, Lopes L, Baracat E, Podgaec S. Dienogest in the treatment of endmetriosis: systematic review. Arch Gynecol Obset. 2015;292:523\u20139.","journal-title":"Arch Gynecol Obset"},{"key":"1795_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/09513590701584923","volume":"23","author":"KW Schweppe","year":"2007","unstructured":"Schweppe KW. Long-term use progestogens\u2013 effects on endometriosis, adenomyosis and myomas. Gynecol Endocrinol. 2007;23:17\u201321.","journal-title":"Gynecol Endocrinol"},{"key":"1795_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/bjc.2012.26","volume":"106","author":"Y Bono","year":"2012","unstructured":"Bono Y, Kyo S, Takakura M, Maida Y, Mizumoto Y, Nakamura M, Nomura K, Kiyono T, Inoue M. Creation of immortalised epithelial cells from ovarian endometrioma. Br J Cancer. 2012;106:1205\u201313.","journal-title":"Br J Cancer"},{"key":"1795_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0014-5793(96)00639-4","volume":"390","author":"PB Rasmussen","year":"1996","unstructured":"Rasmussen PB, Bj\u00f8rn S, Hastrup S, Nielsen PF, Norris K, Thim L, Wiberg FC, Flodgaard H. Characterization of recombinant human HBP\/CAP37\/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes. FEBS Lett. 1996;390:109\u201312.","journal-title":"FEBS Lett"},{"key":"1795_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jb\/mvh020","volume":"135","author":"Y Okuyama","year":"2004","unstructured":"Okuyama Y, Cho J, Nakajima Y, Homma K, Sekimizu K, Natori S. Binding between azurocidin and calreticulin: its involvement in the activation of peripheral monocytes. J Biochem. 2004;135:171\u20137.","journal-title":"J Biochem"},{"key":"1795_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.phrs.2005.01.004","volume":"51","author":"B Lauritzen","year":"2005","unstructured":"Lauritzen B, Lykkesfeidt J, Djurup R, Flodgaard H, Svendsen. Effect of heparin-binding protein (CAP37\/azurocidin) in a porcine model of Actinobacillus pleuropneumoniae-induced pneumonia. Pharmacol Res. 2005;51:509\u201314.","journal-title":"Pharmacol Res"},{"key":"1795_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","volume":"98","author":"RO Burney","year":"2012","unstructured":"Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98:511\u20139.","journal-title":"Fertil Steril"},{"key":"1795_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/humupd\/dmz005","volume":"25","author":"BD Yilmaz","year":"2019","unstructured":"Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Update. 2019;25:473\u201385.","journal-title":"Hum Reprod Update"},{"key":"1795_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/humupd\/dmu056","volume":"21","author":"B Patel","year":"2015","unstructured":"Patel B, Elguero S, Thakore S, Dahoud W, Bedaiwy M, Mesiano S. Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum Reprod Update. 2015;21:155\u201373.","journal-title":"Hum Reprod Update"},{"key":"1795_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1757-2215-5-31","volume":"5","author":"A Hayashi","year":"2012","unstructured":"Hayashi A, Tanabe A, Kawabe S, Hayashi M, Yuguchi H, Yamashita Y, Okuda K, Ohmichi M. Dienogest increases the progesterone receptor isoform B\/A ratio in patients with ovarian endometriosis. J Ovarian Res. 2012;5:31.","journal-title":"J Ovarian Res"},{"key":"1795_CR35","first-page":"2897","volume":"85","author":"GR Attia","year":"2000","unstructured":"Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85:2897\u2013902.","journal-title":"J Clin Endocrinol Metab"},{"key":"1795_CR36","first-page":"30","volume":"52","author":"R Misao","year":"1999","unstructured":"Misao R, Iwagaki S, Fujimoto J, Sun W, Tamaya T. Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis. Horm Res. 1999;52:30\u20134.","journal-title":"Horm Res"},{"key":"1795_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jsbmb.2014.12.008","volume":"147","author":"M Ichioka","year":"2015","unstructured":"Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, Bono Y, Kyo S. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms a and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015;147:103\u201310.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1795_CR38","first-page":"158","volume":"38","author":"T Igarashi","year":"2017","unstructured":"Igarashi T, Morioka M, Komura A, Nakamura H, Kouso T, Nakamura Y, Tsuruga T, Hayashi M, Liang S, Yamazaki K, Yamada M, Ishida Y. Is endometriosis (endometriosis) lesion epithelial PR down-regulation by genogest associated with clinical efficacy? J Japan Soc Endometr. 2017;38:158\u201361.","journal-title":"J Japan Soc Endometr"},{"key":"1795_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/aogs.13156","volume":"96","author":"BG Patel","year":"2017","unstructured":"Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand. 2017;96:623\u201332.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1795_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/epi.1.2.2766","volume":"1","author":"Y Wu","year":"2016","unstructured":"Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform in endometriosis. Epigenetics. 2016;1:106\u201311.","journal-title":"Epigenetics"},{"key":"1795_CR41","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.3390\/ijms24086992","volume":"24","author":"P Zhang","year":"2023","unstructured":"Zhang P, Wang G. Progesterone resistance in endometriosis: current and putative mechanisms. Int J Mol Sci. 2023;24:6992. https:\/\/doi.org\/10.3390\/ijms24086992.","journal-title":"Int J Mol Sci"},{"key":"1795_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/bmc-2019-0017","volume":"10","author":"G Anderson","year":"2019","unstructured":"Anderson G. Endometriosis pathoetiology and pathophysiology. Roles of vitamin A, estrogen, immunity, adipocytes, gut microbiome and melatonergic pathway on mitochondria regulation. Biomol Concepts. 2019;10:133\u201349.","journal-title":"Biomol Concepts"},{"key":"1795_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0031-1299596","volume":"30","author":"EB Serdar","year":"2012","unstructured":"Serdar EB, Diana M, Mary EP, Matthew D, Qing X, Erkut A, Hideki T, Emily JS. Role of estrogen recepter-\u03b2 in endometriosis. Semin Reprod Med. 2012;30:39\u201345.","journal-title":"Semin Reprod Med"},{"key":"1795_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1056\/NEJMra0804690","volume":"360","author":"SE Bulun","year":"2009","unstructured":"Bulun SE, Endometriosis. N Engl J Med. 2009;360:268\u201379.","journal-title":"N Engl J Med"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01795-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-01795-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01795-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T08:07:27Z","timestamp":1740816447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-01795-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-01795-w","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"type":"print","value":"1933-7191"},{"type":"electronic","value":"1933-7205"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our institution\u2019s IRB (IRB No. H28-037_673-03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors read the final version of the manuscript and consented to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}